SANUWAVE Health Inc. (SNWV)
SNWV trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$5.61
-3.94% on the day
Market cap
$48.3M
Nano cap
Revenue · 2025
$44.1M
+35.0% on 2024
Net income · 2025
$11.8M
26.8% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | SNWV on Nasdaq |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001417663 |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Incorporated in | NV |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $44.1M |
| Net income | $11.8M |
| Operating income | $4.9M |
| Net margin | 26.8% |
| Operating margin | 11.2% |
| Revenue growth | +35.0% |
| Cash | $12.0M |
| Total assets | $37.3M |
| P/E (computed) | 4.1× |
| P/S (computed) | 1.1× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-1 | 2024-12-03 |
| Latest annual report | 10-K | 2026-03-26 |
| Latest quarterly / interim | 10-Q | 2026-08-06 |
| Latest current report | 8-K | 2026-09-25 |
| Latest proxy | DEFA14A | 2026-04-29 |
Source: SEC EDGAR submissions feed, 750 recent filings. All filings on EDGAR.
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| TELA | TELA Bio Inc. | $1.06 | -1.39% | $48.1M |
| SRTS | Sensus Healthcare Inc. | $2.89 | -1.36% | $47.6M |
| MDAI | Spectral AI Inc. | $1.56 | -2.50% | $50.2M |
| XTNT | Xtant Medical Holdings Inc. | $0.3243 | -1.43% | $45.5M |
| GUTS | Fractyl Health Inc. | $4.03 | -8.73% | $53.4M |
| DRIO | DarioHealth Corp. | $5.54 | +2.21% | $54.3M |
| NEPH | Nephros Inc. | $3.59 | +0.56% | $39.0M |
| DXR | Daxor Corporation | $10.35 | +0.45% | $60.4M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier